Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior

Tumors are associated with altered or deregulated gene products that affect critical cellular functions. Here we assess the use of a global expression profiling technique that identifies chromosome regions corresponding to differential gene expression, termed comparative expressed sequence hybridization (CESH). CESH analysis was performed on a total of 104 tumors with a diagnosis of rhabdomyosarcoma, leiomyosarcoma, prostate cancer, and favorable‐histology Wilms tumors. Through the use of the chromosome regions identified as variables, support vector machine analysis was applied to assess classification potential, and feature selection (recursive feature elimination) was used to identify the best discriminatory regions. We demonstrate that the CESH profiles have characteristic patterns in tumor groups and were also able to distinguish subgroups of rhabdomyosarcoma. The overall CESH profiles in favorable‐histology Wilms tumors were found to correlate with subsequent clinical behavior. Classification by use of CESH profiles was shown to be similar in performance to previous microarray expression studies and highlighted regions for further investigation. We conclude that analysis of chromosomal expression profiles can group, subgroup, and even predict clinical behavior of tumors to a level of performance similar to that of microarray analysis. CESH is independent of selecting sequences for interrogation and is a simple, rapid, and widely accessible approach to identify clinically useful differential expression. © 2003 Wiley‐Liss, Inc.

[1]  Michael L. Bittner,et al.  cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene , 1999, Nature Genetics.

[2]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[3]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Colin Campbell,et al.  Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones , 2002, Genes, chromosomes & cancer.

[5]  P. Picci,et al.  The expression of ccn3(nov) gene in musculoskeletal tumors. , 2002, The American journal of pathology.

[6]  Yong-jie Lu,et al.  Chromosome 1q expression profiling and relapse in Wilms' tumour , 2002, The Lancet.

[7]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[8]  Joshua M. Stuart,et al.  Chromosomal clustering of muscle-expressed genes in Caenorhabditis elegans , 2002, Nature.

[9]  U. Alon,et al.  Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. , 2001, Cancer research.

[10]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[11]  Trevor Hastie,et al.  The Elements of Statistical Learning , 2001 .

[12]  D. Slonim.  From patterns to pathways: gene expression data analysis comes of age , 2002, Nature Genetics.

[13]  M. Gessler,et al.  Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. , 2001, The American journal of pathology.

[14]  M. Radmacher,et al.  Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. , 2003, Journal of the National Cancer Institute.

[15]  K. Pritchard-Jones,et al.  A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma , 2000, Genes, chromosomes & cancer.

[16]  Yong-jie Lu,et al.  Characterization of chromosome aberrations associated with soft‐tissue leiomyosarcomas by twenty‐four‐color karyotyping and comparative genomic hybridization analysis , 2001, Genes, chromosomes & cancer.

[17]  Roger E Bumgarner,et al.  Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. , 1999, Gene.

[18]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[19]  Nello Cristianini,et al.  Large Margin DAGs for Multiclass Classification , 1999, NIPS.

[20]  WestonJason,et al.  Gene Selection for Cancer Classification using Support Vector Machines , 2002 .

[21]  Lucila Ohno-Machado,et al.  Analysis of matched mRNA measurements from two different microarray technologies , 2002, Bioinform..

[22]  Yudong D. He,et al.  Expression profiling predicts outcome in breast cancer , 2002, Breast Cancer Research.

[23]  Todd,et al.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.

[24]  K. Pritchard-Jones,et al.  Genes, chromosomes, and rhabdomyosarcoma , 1999, Genes, chromosomes & cancer.

[25]  T. Hudson,et al.  Characterization of variability in large-scale gene expression data: implications for study design. , 2002, Genomics.

[26]  Ji Huang,et al.  [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.

[27]  M. Bittner,et al.  Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.

[28]  Rithy K. Roth,et al.  Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays , 2000, Nature Biotechnology.

[29]  Jason Weston,et al.  Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.

[30]  F. Baas,et al.  The Human Transcriptome Map: Clustering of Highly Expressed Genes in Chromosomal Domains , 2001, Science.

[31]  D Williamson,et al.  Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[33]  K. Pritchard-Jones,et al.  Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. , 1996, Cancer research.

[34]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[35]  Jonathan Knight,et al.  When the chips are down , 2001, Nature.

[36]  Sayan Mukherjee,et al.  Estimating Dataset Size Requirements for Classifying DNA Microarray Data , 2003, J. Comput. Biol..

[37]  S. Gould,et al.  Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? , 2001, British Journal of Cancer.

[38]  F. Barr.  Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma , 2001, Oncogene.